PLD - Xtandi - AST-21-URD0301

Articles

Tosoian is developing the Contemporary Uro-oncologic specimens and Protocols (CUSP) program, which will implement prospective collection of the biospecimens and correlative clinical data essential to basic, translational, and clinical genitourinary cancer research.

Dr. Jeffrey Tosoian joins VUMC Department of Urology

Multiple PSMA-PET imaging agents are approved by the FDA for use in prostate cancer. 

NCCN Guidelines add PSMA-PET imaging modalities for prostate cancer

Urology areas covered for this FDA clearance include conditions of the prostate, bladder, kidneys, and genitalia.

FDA grants clearance to soft-tissue 3D printing technology for GU conditions

The SAP program cultivates a community of advocacy groups, medical associations, and medical institutions to foster collaboration and an open exchange of information among trusted peers for the ultimate benefit of patients and their families.

Urology Times Announces the Addition of Five Partners to Strategic Alliance Partnership (SAP) Program

The noninvasive UriFind test identifies bladder cancer based on methylation detection of exfoliated cell DNA in urine.

FDA grants breakthrough designation to novel bladder cancer detection test

The federal agency has issued final guidance on how to design studies that include this patient population. 

FDA finalizes blueprint for cancer drug trials involving patients with CNS metastases

Questions remain surrounding the origin of the global pandemic. 

Unsolved Mystery: Where did COVID-19 come from?

Here are some news items in the urology field you may have missed this week.

Urology Times roundup: obesity paradox, PSMA education, and novel bladder cancer combo

Concepcion is editor-in-chief of Urology Times' sister publication, Urologists in Cancer Care.

US Urology Partners Names Healthcare Visionary Raoul S. Concepcion, MD, as Chief Science Officer

Videos

Lantheus, the developer of piflufolastat F 18, selected oncology provider GenesisCare to administer the first commercially available dose of the agent.

All News